Non-invasive screening of HLA-DPA1 and HLA-DPB1 alleles for persistent hepatitis B virus infection: Susceptibility for vertical transmission and toward a personalized approach for vaccination and treatment

Clinica Chimica Acta

Volumn 412, Issue 11-12, 2011, Pages 952-957

  Lau, Kin Chong ^a   Lam, Ching Wan ^a   Law, Chun Yiu ^b   Lai, Sik To ^b   Tsang, Tak Yin ^b   Siu, Carol Wai Kwan ^b   To, Wing Kin ^c   Leung, Ka Fai ^a   Mak, Chloe Miu ^b   Poon, Wing Tat ^b   Chan, Paul Kay Sheung ^d   Chan, Yan Wo ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b PRINCESS MARGARET HOSPITAL   (Hong Kong)

^c Kowloon West Cluster ^*  (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chronic hepatitis B; Host genetic risk factor; Salivary diagnostic

Indexed keywords

FORKHEAD BOX PROTEIN P1; GENOMIC DNA; HLA ANTIGEN; HLA DPA1 ANTIGEN; HLA DPB1 ANTIGEN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; DNA EXTRACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VERTICAL TRANSMISSION;

HEPATITIS B VIRUS;

EID: 79955046277     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2011.01.030     Document Type: Article

References (31)

1. Zhang S., Chen Y. HBV serum marker detection and relative factor analysis of 2925 new students. Public Health 1998, 112:257-259.
2. Lok A.S.F., Lai C.L., Wu P.C., Wong V.C.W., Yeoh E.K., Lin H.J. Hepatitis B virus infection in Chinese families in Hong Kong. Am J Epidemiol 1987, 126:492-499.
3. Kwan L.C., Ho Y.Y., Lee S.S. The declining HBsAg carriage rate in pregnant women in Hong Kong. Epidemiol Infect 1997, 119:281-283.
4. Lok A.S.F., Lai C.L., Wu P.C., Ng M.M.T. Response to hepatitis B vaccine in family members of HBsAg carriers. J Med Virol 1986, 19:33-39.
5. Zuckerman J.N. Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines. J Med Virol 2006, 78:169-177.
6. HÖhler T., Reuss E., Evers N., Dietrich E., Rittner C., Freitag C.M., et al. Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus; a vaccination study in twins. Lancet 2002, 360:991-995.
7. Jiang Y.G., Wang Y.M., Liu T.H., Liu J. Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B. World J Gastroenterol 2003, 9:2221-2225.
8. Deng G., Zhou G., Zhai Y., Li S., Li X., Li Y., et al. Association of estrogen receptor alpha polymorphisms with susceptibility to chronic hepatitis B virus infection. Hepatology 2004, 40:318-326.
9. Kamatani Y., Wattanapokayakit S., Ochi H., Kawaguchi T., Takahashi A., Hosono N., et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009, 41:591-595.
10. Rauch A., Kutalik Z., Descombes P., Cai T., Di Iulio J., Mueller T. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010, 138:1338-1345.
11. Lau G.K., Ye D. Novel insights into the association between HLA-DP variants and persistent hepatitis B virus infection: a genome-wide association study. Gastroenterology 2010, 138:394-396.
12. Howell J.A., Visvanathan K. A novel role for human leukocyte antigen-DP in chronic hepatitis B infection: a genomewide association study. Hepatology 2009, 50:647-649.
13. Davila S., Froeling F.E.M., Tan A., Bonnard C., Boland G.J., Snippe H., et al. New genetic associations detected in a host response study to hepatitis B vaccine. Genes Immun 2010, 11:232-238.
14. Hu H., Wang B., Borde M., Nardone J., Maika S., Allred L., et al. Foxp1 is an essential transcriptional regulator of B cell development. Nat Immunol 2006, 7:819-826.
15. Henning B.J., Fielding K., Broxholme J., Diatta M., Mendy M., Moore C., et al. Host genetic factors and vaccine-induced immunity to hepatitis B virus infection. PLoS ONE 2008, 3:e1898.
16. Hansen T.V., Simonsen M.K., Nielsen F.C., Hundrup Y.A. Collection of blood, saliva, and buccal cell samples in a pilot study on the Danish nurse cohort: comparison of the response rate and quality of genomic DNA. Cancer Epidemiol Biomark Prev 2007, 16:2072-2076.
17. Nishita D.M, Jack L.M, McElroy M., McClure J.B., Richards J., Swan G.E., et al. Clinical trial participant characteristics and saliva and DNA metrics. BMC Med Res Methodol 2009, 9:71.
18. Ng D.P.K., Koh D., Choo S., Chia K.S. Saliva as a viable alternative source of human genomic DNA in genetic epidemiology. Clin Chim Acta 2006, 367:81-85.
19. Thursz M. Genetic susceptibility in chronic viral hepatitis. Antivir Res 2001, 52:113-116.
20. Wang F.S. Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection. World J Gastroenterol 2003, 9:641-644.
21. Zhao Y.R., Gong L., He Y.L., Liu F., Lu C. Relationship between polymorphism of class II transactivator gene promoters and chronic hepatitis B. World J Gastroenterol 2005, 11:854-857.
22. Duan Z.P., Zhao X.Y., Huang D.Z., He L.X., Chen Y., Zhao C.H., et al. RANTES gene single nucleotide polymorphisms and expression in patients with chronic hepatitis B virus infection. Chin Med J 2005, 118:909-914.
23. He Y.L., Zhao Y.R., Zhang S.L., Chen W., Lin S., Yang Q., et al. Not polymorphism but methylation of class II transactivator gene promoter IV associated with persistent HBV infection. J Clin Virol 2006, 37:282-286.
24. Almarri A., Batchelor J.R. HLA and hepatitis B infection. Lancet 1994, 344:1194-1195.
25. Thursz M.R., Kwiatkowski D., Allsopp C.E., Greenwood B.M., Thomas H.C., Hill A.V. Association between an MHC class II allele and clearance of hepatitis B virus in Gambia. N Engl J Med 1995, 332:1065-1069.
26. Thursz M.R., Thomas H.C., Greenwood B.M., Hill A.V. Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nat Genet 1997, 17:11-12.
27. Zinkernagel R.M. Immunology taught by viruses. Science 1996, 271:173-178.
28. van der Eijk A.A., Niesters H.G., GÖtz H.M., Janssen H.L., Schalm S.W., Osterhaus A.D., et al. Paired measurements of quantitative hepatitis B virus DNA in saliva and serum of chronic hepatitis B patients: implications for saliva as infectious agent. J Clin Virol 2004, 29:92-94.
29. Heiberg I.L., Hoegh M., Ladelund S., Niesters H.G., Hogh B. Hepatitis B virus DNA in saliva from children with chronic hepatitis B infection: implications for saliva as a potential mode of horizontal transmission. Pediatr Infect Dis J 2010, 29:465-467.
30. Scott R.M., Snitbhan R., Bancroft W.H., Alter H.J., Tingpalapong M. Experimental transmission of hepatitis B virus by semen and saliva. J Infect Dis 1980, 142:67-71.
31. Bahlo M., Stankovich J., Danoy P., Hickey P.F., Taylor B.V., Browning S.R., et al. Saliva-derived DNA performs well in large-scale, high-density single-nucleotide polymorphism microarray studies. Cancer Epidemiol Biomark Prev 2010, 19:794-798.